Restoring Blood Flow.
Restoring Life.

Treating today's atherosclerotic disease requires a new generation of tools for better outcomes.

Learn More

Opening Blocked Arteries Requires a New Approach

An aging population and unhealthy lifestyles make atherosclerotic disease a leading health issue throughout the world.

Learn More

Empower Your Angioplasty

Serranator White logo

Serration Balloon Technology is the next evolution in the treatment of Peripheral Artery Disease (PAD).

Learn More

A Global Health
Challenge

A Growing Population icon

A Growing Population

Widespread increases in diabetes, obesity, and smoking have given rise to the increase of atherosclerotic disease worldwide.

Heart beat icon

An Evolving Condition

Long, occluded, and heavily calcified lesions are becoming the norm: adding complexity to patient treatment.

Providing Endovascular Specialists with Better Solutions

LEARN MORE
BTK curved Trans
Cagent Serranator white logo

Improving Angioplasty For Better Outcomes

Over 1,000 times more focal force than a plain balloon.

Learn More

Serrations:
A Proven Technology​

Step 3 icon
Step 2 icon
Step 1 icon

Based on physics principles, focused force along multiple interrupted points results in a controlled, predictable cracking effect, even at low pressure.

Learn More

What are Physicians Saying?

A new approach to vessel dilatation is long overdue for treatment of diseased peripheral arteries. Today, we are treating more complex lesions that require better tools. We believe Serration Technology is effective in treating these complex lesions and will evolve into the new standard of care for vessel dilatation.
– Peter Schneider, MD, Vascular Surgeon
Excellent acute results were achieved with 100% device success and a very low bail out stent rate despite a significant number of lesions containing chronic total occlusions and severe calcification. Interestingly, IVUS and OCT confirmed serrations were visible in all imaged patients.
- Andrew Holden, MBChB, FRANZCR, EBIR
The Serranator is unique in that it combines an effective vessel dilatation technology and a highly deliverable system on a single platform. In my experience, it is quite effective in calcified or highly fibrotic lesions where balloon angioplasty has historically fallen short.
- Mahmood Razavi, MD, Interventional Radiologist

Recent News

Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication 

Cagent Vascular®, a developer of next generation angioplasty balloons using proprietary serration technology, also announces completion of its PRELUDE-BTK clinical trial enrollment.

Read More